Research Topics
| Sunil V RaoSummaryAffiliation: Duke University Medical Center Country: USA Publications
| Collaborators
|
Detail Information
Publications
Association between periprocedural bleeding and long-term outcomes following percutaneous coronary intervention in older patientsSunil V Rao
Duke Clinical Research Institute, Durham, North Carolina 27705, USA
JACC Cardiovasc Interv 5:958-65. 2012..The authors sought to describe the association between post-procedural bleeding and long-term recurrent bleeding, major adverse cardiac events (MACE), and mortality among older patients undergoing percutaneous coronary intervention (PCI)...
Socioeconomic status and outcome following acute myocardial infarction in elderly patientsSunil V Rao
Duke Clinical Research Institute, 2400 Pratt Street, Durham, NC 27715, USA
Arch Intern Med 164:1128-33. 2004..Whether these disparities account for increased mortality among elderly poor patients is not known...
Postmarket evaluation of breakthrough technologiesSunil V Rao
Duke Clinical Research Institute and Duke University Medical Center, Durham, NC 27705, USA
Am Heart J 156:201-8. 2008....
Prevalence and outcomes of same-day discharge after elective percutaneous coronary intervention among older patientsSunil V Rao
Duke Clinical Research Institute, 508 Fulton St, Durham, North Carolina, USA
JAMA 306:1461-7. 2011..Patients undergoing elective percutaneous coronary intervention (PCI) are generally observed overnight in the hospital. The association between same-day discharge of older patients and death or readmission is unclear...
Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromesSunil V Rao
The Duke Clinical Research Institute, Durham, North Carolina, USA
Am J Cardiol 96:1200-6. 2005..Therapies that minimize bleeding risk and maintain an anticoagulant effect may improve outcomes among patients who have ACS...
A comparison of the clinical impact of bleeding measured by two different classifications among patients with acute coronary syndromesSunil V Rao
Duke Clinical Research Institute, Durham, North Carolina 27715, USA
J Am Coll Cardiol 47:809-16. 2006..The goal of this study was to determine the association between Thrombolysis In Myocardial Infarction (TIMI) and Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) bleeding and clinical outcomes...
Association between bleeding, blood transfusion, and costs among patients with non-ST-segment elevation acute coronary syndromesSunil V Rao
The Duke Clinical Research Institute, Durham, NC 27705, USA
Am Heart J 155:369-74. 2008..We sought to determine the relationship between bleeding, blood transfusion, and measures of costs among patients with non-ST-segment elevation ACS...
On- versus off-label use of drug-eluting coronary stents in clinical practice (report from the American College of Cardiology National Cardiovascular Data Registry [NCDR])Sunil V Rao
Duke Clinical Research Institute, Durham, North Carolina, USA
Am J Cardiol 97:1478-81. 2006..Randomized clinical trials are needed to confirm the efficacy of DESs in these clinical and angiographic settings. These data also highlight the importance of multicenter registries in tracking new technologies...
Patterns and outcomes of drug-eluting coronary stent use in clinical practiceSunil V Rao
The Duke Clinical Research Institute, Durham, NC 27705, USA
Am Heart J 152:321-6. 2006..To determine patterns and outcomes of drug-eluting stents (DES) use in clinical practice...
Clinical outcomes with drug-eluting stents following atheroablation therapiesSunil V Rao
Durham Veterans Affairs Medical Center and the Duke Clinical Research Institute, Durham, North Carolina 27705, USA
J Invasive Cardiol 18:393-6. 2006..Because these techniques are still required in a minority of patients, we hypothesized that the use of drug-eluting stents (DES) would minimize the rate of major adverse cardiac events (MACE) after atheroablation...
Standardized reporting of bleeding complications for clinical investigations in acute coronary syndromes: a proposal from the academic bleeding consensus (ABC) multidisciplinary working groupSunil V Rao
Duke Clinical Research Institute, Durham, NC 27705, USA
Am Heart J 158:881-886.e1. 2009..Clinical trials of antithrombotic agents for the treatment of ACS routinely assess bleeding as a safety endpoint, but variation in bleeding definitions makes comparison of the relative safety of these agents difficult...
Trends in the prevalence and outcomes of radial and femoral approaches to percutaneous coronary intervention: a report from the National Cardiovascular Data RegistrySunil V Rao
The Duke Clinical Research Institute, Durham, North Carolina, USA
JACC Cardiovasc Interv 1:379-86. 2008..Our goal was to compare trends in the prevalence and outcomes of the radial and femoral approaches to percutaneous coronary intervention (PCI) in contemporary clinical practice...
Prognostic value of isolated troponin elevation across the spectrum of chest pain syndromesSunil V Rao
Duke Clinical Research Institute, PO Box 17969, Durham, NC 27715, USA
Am J Cardiol 91:936-40. 2003..This suggests that these patients should be admitted to the hospital and monitored in either an intensive care or step-down unit...
Poverty, process of care, and outcome in acute coronary syndromesSunil V Rao
Duke Clinical Research Institute, dDuke University, PO Box 17969, Durham, NC 27715, USA
J Am Coll Cardiol 41:1948-54. 2003..We sought to determine whether income-based disparities in care processes and outcome exist in patients with acute coronary syndromes...
The transradial approach to percutaneous coronary intervention: historical perspective, current concepts, and future directionsSunil V Rao
The Duke Clinical Research Institute, Durham, NC, USA
J Am Coll Cardiol 55:2187-95. 2010..Finally, we describe potential directions for future investigation in the transradial realm...
International variation in the use of blood transfusion in patients with non-ST-segment elevation acute coronary syndromesSunil V Rao
The Duke Clinical Research Institute, Durham, North Carolina, USA
Am J Cardiol 101:25-29. 2008....
Evaluation of a new heparin agent in percutaneous coronary intervention: results of the phase 2 evaluation of M118 IN pErcutaNeous Coronary intErvention (EMINENCE) TrialSunil V Rao
Duke Clinical Research Institute, Durham, NC, USA
Circulation 121:1713-21. 2010..We performed a phase 2 randomized trial to evaluate the safety and feasibility of M118 in the setting of elective percutaneous coronary intervention...
Strategies to reduce bleeding among patients with ischemic heart disease treated with antiplatelet therapiesSunil V Rao
Duke Clinical Research Institute, Durham, NC 27705, USA
Am J Cardiol 104:60C-3C. 2009....
Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromesSunil V Rao
Duke Clinical Research Institute, Durham, NC 27715, USA
JAMA 292:1555-62. 2004..It is unclear if blood transfusion in anemic patients with acute coronary syndromes is associated with improved survival...
Bleeding and blood transfusion issues in patients with non-ST-segment elevation acute coronary syndromesSunil V Rao
The Duke Clinical Research Institute, Durham, NC, USA
Eur Heart J 28:1193-204. 2007..Future directions for research and clinical practice are also discussed...
Short- and long-term outcomes of coronary stenting in women versus men: results from the National Cardiovascular Data Registry Centers for Medicare & Medicaid services cohortMonique L Anderson
7022 N Pavilion DUMC, PO Box 17969, Durham, NC 27715, USA
Circulation 126:2190-9. 2012..Conflicting evidence exists on sex-based outcomes after coronary stenting...
Race, Bleeding, and Outcomes in STEMI Patients Treated with Fibrinolytic TherapyRajendra H Mehta
Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27715, USA
Am J Med 124:48-57. 2011....
Evidence-based therapies and mortality in patients hospitalized in December with acute myocardial infarctionTrip J Meine
Duke University Medical Center, Durham, North Carolina, USA
Ann Intern Med 143:481-5. 2005..CONCLUSIONS: Thirty-day mortality rates were higher for Medicare patients hospitalized with acute MI in December than in other months, although the use of evidence-based therapies was not significantly lower...
The association of in-hospital major bleeding with short-, intermediate-, and long-term mortality among older patients with non-ST-segment elevation myocardial infarctionRenato D Lopes
Duke Clinical Research Institute, Box 3850, 2400 Pratt Street, Room 0311, Terrace Level, Durham, NC 27705, USA
Eur Heart J 33:2044-53. 2012..Their association with long-term outcomes is less clear. This study examines mortality associated with in-hospital bleeding during NSTEMI over time intervals starting from hospital discharge and extending past 3 years...
Trends and predictors of length of stay after primary percutaneous coronary intervention: a report from the CathPCI registryChee Tang Chin
Duke Clinical Research Institute, Durham, NC, USA
Am Heart J 162:1052-61. 2011..The extent to which ST-segment elevation myocardial infarction patients are discharged early after primary percutaneous coronary intervention (PPCI) in current practice is unknown...
Antiplatelet therapy use after discharge among acute myocardial infarction patients with in-hospital bleedingTracy Y Wang
Duke Clinical Research Institute, 2400 Pratt St, Room 0311, Terrace Level, Durham, NC 27705, USA
Circulation 118:2139-45. 2008..Although the mechanism underlying this association is unclear, a potential explanation is that withholding antiplatelet therapies long beyond resolution of the bleeding event may contribute to recurrent events...
Contemporary mortality risk prediction for percutaneous coronary intervention: results from 588,398 procedures in the National Cardiovascular Data RegistryEric D Peterson
Duke Clinical Research Institute, Durham, North Carolina 27715, USA
J Am Coll Cardiol 55:1923-32. 2010..We sought to create contemporary models for predicting mortality risk following percutaneous coronary intervention (PCI)...
Characteristics and long-term outcomes of percutaneous revascularization of unprotected left main coronary artery stenosis in the United States: a report from the National Cardiovascular Data Registry, 2004 to 2008J Matthew Brennan
Department of Medicine, Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina 27705, USA
J Am Coll Cardiol 59:648-54. 2012..This study sought to assess percutaneous coronary intervention (PCI) for unprotected left main coronary artery (ULMCA) stenosis in routine U.S. clinical practice...
The impact of postrandomization crossover of therapy in acute coronary syndromes careKenneth W Mahaffey
Division of Cardiology and Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27715, USA
Circ Cardiovasc Qual Outcomes 4:211-9. 2011..Using SYNERGY as an example, we demonstrate the difficulty of evaluating the effect of postrandomization events in clinical trials and discuss possible methodology...
Transfusion practice and outcomes in non-ST-segment elevation acute coronary syndromesKaren P Alexander
Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27715, USA
Am Heart J 155:1047-53. 2008..To describe the association between transfusion and outcomes as a function of nadir hematocrit (HCT) in patients with non-ST-segment elevation acute coronary syndromes (NSTE ACS)...
Economic assessment of thrombocytopenia: CATCH RegistryEric L Eisenstein
Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27705, USA
J Med Syst 34:379-86. 2010..001); and (group 3) (difference, $27,077; 95% CI, $22,901-$31,252; P<.001). However, in our adjusted model, longer lengths-of-stay and greater use of blood transfusions accounted for most incremental in-hospital cost differences...
The implications of blood transfusions for patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE National Quality Improvement InitiativeXin Yang
Division of Cardiology and Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina 27715, USA
J Am Coll Cardiol 46:1490-5. 2005..Given the wide variation in transfusion practice, further efforts to understand patient and process factors that result in bleeding and need for transfusion in NSTE ACS are needed...
Bleeding and the use of antiplatelet agents in the management of acute coronary syndromes and atrial fibrillationJohn P Vavalle
The Duke Clinical Research Institute, Durham, NC, USA
Adv Cardiol 47:125-40. 2012..Understanding the risk of bleeding associated with antiplatelet agents is critical to developing strategies to mitigate this risk...
Temporal trends in and factors associated with bleeding complications among patients undergoing percutaneous coronary intervention: a report from the National Cardiovascular Data CathPCI RegistrySumeet Subherwal
Duke Clinical Research Institute, Durham, NC 27705, USA
J Am Coll Cardiol 59:1861-9. 2012....
Variation in the use of stress testing and outcomes in patients with non-ST-elevation acute coronary syndromes: insights from GUSTO IIbRajendra H Mehta
Duke Clinical Research Institute, Duke University Medical Center, Box 17969, Durham, NC 27715, USA
Eur Heart J 29:880-7. 2008....
State-mandated continuing medical education and the use of proven therapies in patients with an acute myocardial infarctionManesh R Patel
Duke Clinical Research Institute, Durham, North Carolina 27715, USA
J Am Coll Cardiol 44:192-8. 2004..The purpose of this study was to determine whether state-mandated continuing medical education (CME) requirements affect the use of evidence-based therapies and outcomes in patients with acute myocardial infarction (AMI)...
Bivalirudin: a review of the pharmacology and clinical applicationDavid A Van De Car
Duke University Medical Center, Division of Cardiology, 2301 Erwin Road, Durham, NC, USA
Expert Rev Cardiovasc Ther 8:1673-81. 2010..Additional agents in the class of direct thrombin inhibitors are under investigation and may find increasing clinical use...
Association of bleeding and in-hospital mortality in black and white patients with st-segment-elevation myocardial infarction receiving reperfusionRajendra H Mehta
Duke Clinical Research Institute, Box 17969, Durham, NC 27715, USA
Circulation 125:1727-34. 2012..Additionally, it is unknown whether there are racial differences in bleeding risks among patients with ST-segment-elevation myocardial infarction receiving primary percutaneous coronary intervention...
Design and rationale of the Reduction of Infarct Expansion and Ventricular Remodeling with Erythropoietin after Large Myocardial Infarction (REVEAL) trialChiara Melloni
Division of Cardiology, Department of Medicine, Duke University School of Medicine, Durham, NC, USA
Am Heart J 160:795-803.e2. 2010..Animal models of ischemia/reperfusion have demonstrated that single-dose erythropoietin may reduce infarct size, decrease apoptosis, and increase neovascularization, possibly through mobilization of endothelial progenitor cells...
Design and rationale of the Evaluation of M118 IN pErcutaNeous Coronary intErvention (EMINENCE) trialChiara Melloni
Duke Clinical Research Institute, Durham, NC, USA
Am Heart J 158:726-33. 2009....
Prevalence, predictors, and in-hospital outcomes of non-infarct artery intervention during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction (from the National Cardiovascular Data Registry)Matthew A Cavender
Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA
Am J Cardiol 104:507-13. 2009..These findings suggest the need for definitive studies to evaluate the utility of noninfarct-related artery PCI among patients with STEMI...
Rationale and design of the randomized, double-blind trial testing INtraveNous and Oral administration of elinogrel, a selective and reversible P2Y(12)-receptor inhibitor, versus clopidogrel to eVAluate Tolerability and Efficacy in nonurgent Percutaneous Sergio Leonardi
Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27705, USA
Am Heart J 160:65-72. 2010..The INNOVATE-PCI study is a phase 2 randomized, double-blind, clopidogrel-controlled trial to evaluate the safety, tolerability, and preliminary efficacy of this novel antiplatelet agent in patients undergoing nonurgent PCI...
Long-term clinical outcomes following coronary stentingKevin J Anstrom
Department of Biostatistics, Duke Clinical Research Institute, Durham, NC 27715, USA
Arch Intern Med 168:1647-55. 2008..The objective of this study was to compare the long-term clinical outcomes of patients receiving DES vs BMS in a clinical practice setting...
Highlights from the American Heart Association annual scientific sessions 2001: November 11 to 14, 2001David E Kandzari
Duke Clinical Research Institute, Durham, NC 27715, USA
Am Heart J 143:217-28. 2002
Implications of bleeding and blood transfusion in percutaneous coronary interventionSunil V Rao
Duke Clinical Research Institute, Durham, North Carolina, USA
Rev Cardiovasc Med 8:S18-26. 2007..Using strategies such as careful vascular access, alternative radial artery access, and modified antithrombotic regimen may reduce bleeding during PCI as well as improve patient outcomes...
Anemia in patients undergoing percutaneous coronary intervention: current issues and future directionsTracy Y Wang
Duke University Medical Center, Durham VA Medical Center, Durham, North Carolina, USA
Am J Cardiovasc Drugs 7:225-33. 2007..In addition, we discuss alternative options for the management of anemia, such as the use of erythropoietin, aqueous oxygen, and hemoglobin-based oxygen carriers...
Highlights from the American College of Cardiology Annual Scientific Sessions 2003: March 28 to April 2, 2003John L Petersen
Duke Clinical Research Institute, Durham, NC, USA
Am Heart J 146:19-26. 2003
Bleeding as a predictor of mortality riskSunil V Rao
Durham VA Medical Center, Duke Clinical Research Institute, Durham, North Carolina, USA
Rev Cardiovasc Med 7:S12-8. 2006..Findings suggest that in the modern era of percutaneous coronary intervention, prevention of bleeding should be a goal of therapy, which can be achieved while preserving the low rate of ischemic complications...
Device therapy in the management of congestive heart failureAslan T Turer
Department of Cardiology, Duke University, Durham, NC 27710, USA
Cardiol Rev 13:130-8. 2005....
Bleeding and acute coronary syndromes: defining, predicting, and managing risk and outcomesSharif A Halim
Division of Cardiology, Duke University Medical Center, Durham, NC 27710, USA
Curr Drug Targets 12:1831-5. 2011..This review describes the prevalence of bleeding during ACS management, risk for bleeding, and strategies to reduce bleeding risk...
Incidence, outcomes, and management of bleeding in non-ST-elevation acute coronary syndromesAntonio Gutierrez
Duke University Medical Center, 2301 Erwin Road, Durham, NC 27710, USA
Cleve Clin J Med 77:369-79. 2010..The authors review the scope of the problem and ways to prevent and manage bleeding in this situation...
The association between the transradial approach for percutaneous coronary interventions and bleedingJohn P Vavalle
Duke University Medical Center, Division of Cardiovascular Medicine, Durham, NC 27710 0001, USA
J Invasive Cardiol 21:21A-24A. 2009..Growing data to support the superior clinical outcomes with radial artery PCI, coupled with improved awareness of this data, may lead to increases in its adoption and improved clinical outcomes and mortality after PCI...
Major bleeding: management and risk reduction in acute coronary syndromesMatthew A Cavender
Duke University Medical Center, Department of Medicine, Box 31110 Durham, NC 27710, USA
Expert Opin Pharmacother 9:1869-83. 2008..While this strategy reduces ischemic complications, it places patients at risk for bleeding complications...
The challenge of defining bleeding among patients with acute coronary syndromesThomas W Wallace
Duke Clinical Research Institute, Durham, North Carolina, USA
Clin Cardiol 30:II16-23. 2007....
Association of systemic lupus erythematosus with angiographically defined coronary artery disease: A retrospective cohort studyMala S Kaul
Duke University Medical Center, Durham, North Carolina
Arthritis Care Res (Hoboken) 65:266-73. 2013..We compared the extent of angiographic abnormalities, CAD risk factors, and all-cause mortality in SLE patients with non-SLE controls...
Highlights from the American Heart Association annual scientific sessions 2002: November 17 to 20, 2002Jean-Pierre Dery
Duke Clinical Research Institute, Durham, NC 27715, USA
Am Heart J 145:554-62. 2003
Assessing quality in the cardiac catheterization laboratorySunil V Rao
Duke Clinical Research Institute, Durham NC 27710, USA
Am Heart Hosp J 1:289-96. 2003..Given the dynamic nature of cardiology, adaptable quality assurance and quality improvement programs will remain the foundation of successful catheterization labs...
Proinflammatory, immunomodulating, and prothrombotic properties of anemia and red blood cell transfusionsKatie M Twomley
Department of Medicine, Duke University Medical Center, Cardiovascular Thrombosis Center, Duke Clinical Research Institute, Durham, NC 27715, USA
J Thromb Thrombolysis 21:167-74. 2006....
Aldehyde dehydrogenase activity allows reliable EPC enumeration in stored peripheral blood samplesThomas J Povsic
Division of Cardiology, Duke University Medical Center, Durham, NC 27710, USA
J Thromb Thrombolysis 28:259-65. 2009....
Remaining challenges and opportunities for improvement in percutaneous transradial coronary proceduresSunil V Rao
The Duke Clinical Research Institute, 508 Fulton Street 111A, Durham, NC, USA
Eur Heart J 33:2521-6. 2012..In addition, a protocol for femoral bailout should be considered to maintain door-to-reperfusion metrics...
Atrial fibrillation and percutaneous coronary intervention: stroke, thrombosis, and bleedingAntonio Gutierrez
Department of Medicine, Duke University School of Medicine, DUMC 3850, Durham, NC, 27710, USA
Curr Treat Options Cardiovasc Med 13:203-14. 2011..Finally, as newer oral anticoagulation agents such as dabigatran and rivaroxaban become available, further research will be required to determine their safety and efficacy in patients with AF undergoing PCI with stenting...
The editor's roundtable: management and treatment of non-ST-segment elevation in acute coronary syndromesWilliam C Roberts
Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas, Texas, USA
Am J Cardiol 101:1580-98. 2008
Pharmacoinvasive management of acute coronary syndrome: incorporating the 2007 ACC/AHA guidelines: the CATH (cardiac catheterization and antithrombotic therapy in the hospital) Clinical Consensus Panel Report--IIIMarc Cohen
Cardiac Cath Lab, 2nd Floor Bridge, Newark Beth Israel Medical Center, 201 Lyons Avenue, Newark, NJ, 07112, USA
J Invasive Cardiol 19:525-38; quiz 539-40. 2007..The addition of statins, angiotensin-converting enzyme (ACE) inhibitors and beta-blockers is also stressed as part of a comprehensive secondary cardioprotective strategy for patients with coronary heart disease...
Strategies for optimizing outcomes in the NSTE-ACS patient The CATH (cardiac catheterization and antithrombotic therapy in the hospital) Clinical Consensus Panel ReportMarc Cohen
J Invasive Cardiol 18:617-39. 2006..The addition of statins, ACE-inhibitors and beta-blockers is also stressed as part of a comprehensive secondary cardioprotective strategy for patients with coronary heart disease...
Association of race with complications and prognosis following acute coronary syndromesCraig R Asher
Department of Cardiology, The Cleveland Clinic Foundation, Weston, Florida, USA
Am J Cardiol 94:792-4. 2004..The 1-year mortality rate was 2.9% for black patients and 2.5% for non-black patients (p = 0.93)...
Patterns of cardiac marker surveillance after elective percutaneous coronary intervention and implications for the use of periprocedural myocardial infarction as a quality metric: a report from the National Cardiovascular Data Registry (NCDR)Tracy Y Wang
J Am Coll Cardiol 51:2068-74. 2008
Erythropoietin, anemia, and orthostatic hypotension: the evidence mountsSunil V Rao
Clin Auton Res 12:141-3. 2002
